Contraceptive Technology Update
RSSArticles
-
Good News Released on Teen Sexual Risk Behaviors
New data from the National Youth Risk Behavior Survey indicate the percentage of high school students who are currently sexually active has been decreasing since 1991, with it dropping from 38% in 1991 to 30% in 2015.
-
New Research Eyes Acupuncture for Women with Menopausal Symptoms
Acupuncture treatments can reduce the number of hot flashes and night sweats associated with menopause by as much as 36%, according to recently published data.
-
Identify Contraceptive Considerations For Female Patients Who Have Diabetes
What should clinicians keep in mind when providing family planning for women with diabetes? Not only are these women at increased risk of macrovascular complications, microvascular complications, and metabolic syndrome, but the reproductive health implications they face include effects on fertility, vaginitis, urinary tract infections, maternal risks, and neonatal risks, says Eleanor Bimla Schwarz, MD, MS, professor of medicine at the University of California, Davis.
-
Task Force Recommends Syphilis Screening For Nonpregnant Persons at Increased Risk
Statistics are troubling: The number of cases of primary and secondary syphilis has been increasing since 2000.
-
The Affordable Care Act & Birth Control Coverage — What Every Family Planning Worker Should Know
What do you know about the Affordable Care Act and its birth control coverage requirement?
-
Zika Update: Sexual Transmission Is More Common Than First Thought
With evidence that sexual transmission of the Zika virus has occurred, public health officials are moving quickly to inform the public and educate healthcare professionals on disease prevention.
-
Screening for Ovarian Cancer: Helpful or Harmful?
Ovarian cancer has the highest mortality of any of the gynecologic cancers. Due to the poor prognosis associated with this disease, researchers have been searching for 50 years for an early detection tool.
-
A Low-Dose Estrogen Capsule Examined as Possibility for Vaginal Atrophy
About 32 million postmenopausal women in the United States are affected by vulvar and vaginal atrophy, which can cause painful sexual activity and urination, as well as vaginal dryness, itching, and irritation. Recent data presented at ENDO 2016, the annual meeting of the Endocrine Society, suggests an investigational low-dose vaginal estrogen capsule may help relieve such symptoms.
-
Medicaid Pushes Forward on Family Planning
With the end of the Obama administration rapidly approaching, federal agencies have stepped up their efforts to finalize long-brewing regulations and guidance. CMS has been particularly active. In April 2016, the agency issued three documents that all have considerable importance for family planning services and providers under Medicaid.
-
Data Suggest Hormonal Therapy Doesn’t Increase VTE Risk in Women on Anticoagulant Therapy
Women on anticoagulant therapy can take estrogen-containing contraception or hormone therapy without an increased risk of blood clots or uterine bleeding, findings from a recent study suggest.